Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System

ConclusionsThis study demonstrates the capability of Sentinel to conduct prospective safety monitoring and raises no new concerns about rivaroxaban safety.

Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Elizabeth A. Chrischilles, Joshua J. Gagne, Bruce Fireman, Jennifer Nelson, Sengwee Toh, Azadeh Shoaibi, Marsha E. Reichman, Shirley Wang, Michael Nguyen, Rongmei Zhang, Rima Izem, Margie R. Goulding, Mary Ross Southworth, David J. Graham, Candace Fuller, Tags: ORIGINAL REPORT Source Type: research